Literature DB >> 22789162

What is a multiple treatments meta-analysis?

A Cipriani1, C Barbui, C Rizzo, G Salanti.   

Abstract

Standard meta-analyses are an effective tool in evidence-based medicine, but one of their main drawbacks is that they can compare only two alternative treatments at a time. Moreover, if no trials exist which directly compare two interventions, it is not possible to estimate their relative efficacy. Multiple treatments meta-analyses use a meta-analytical technique that allows the incorporation of evidence from both direct and indirect comparisons from a network of trials of different interventions to estimate summary treatment effects as comprehensively and precisely as possible.

Entities:  

Mesh:

Year:  2012        PMID: 22789162     DOI: 10.1017/S2045796011000837

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  6 in total

Review 1.  Addressing multimorbidity in evidence integration and synthesis.

Authors:  Thomas A Trikalinos; Jodi B Segal; Cynthia M Boyd
Journal:  J Gen Intern Med       Date:  2014-01-18       Impact factor: 5.128

2.  Simultaneous Comparison of Efficacy and Tolerability of Second-Generation Antipsychotics in Schizophrenia: Mixed-Treatment Comparison Analysis Based on Head-to-Head Trial Data.

Authors:  Gyu Han Oh; Je-Chun Yu; Kyeong-Sook Choi; Eun-Jeong Joo; Seong-Hoon Jeong
Journal:  Psychiatry Investig       Date:  2014-10-01       Impact factor: 2.505

3.  Approaches to interpreting and choosing the best treatments in network meta-analyses.

Authors:  L Mbuagbaw; B Rochwerg; R Jaeschke; D Heels-Andsell; W Alhazzani; L Thabane; Gordon H Guyatt
Journal:  Syst Rev       Date:  2017-04-12

Review 4.  A comparative assessment of three formulations of botulinum toxin A for facial rhytides: a systematic review and meta-analyses.

Authors:  James P Bonaparte; David Ellis; Jason G Quinn; Mohammed T Ansari; Jessica Rabski; Shaun J Kilty
Journal:  Syst Rev       Date:  2013-06-13

5.  Capecitabine, 5-fluorouracil and S-1 based regimens for previously untreated advanced oesophagogastric cancer: A network meta-analysis.

Authors:  Emil Ter Veer; Lok Lam Ngai; Gert van Valkenhoef; Nadia Haj Mohammad; Maarten C J Anderegg; Martijn G H van Oijen; Hanneke W M van Laarhoven
Journal:  Sci Rep       Date:  2017-08-02       Impact factor: 4.379

6.  The Use of (Network) Meta-Analysis in Clinical Oncology.

Authors:  Emil Ter Veer; Martijn G H van Oijen; Hanneke W M van Laarhoven
Journal:  Front Oncol       Date:  2019-08-27       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.